Over the past 12 months, 0 insiders at 89bio, Inc. filed 0 open-market SEC Form 4 transactions on ETNB: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 25 | Quoc Le-nguyenSee Remarks | SELL | 10.5K | $11.02 | $115K |
| Apr 15, 25 | Quoc Le-nguyenSee Remarks | SELL | 15.3K | $5.95 | $91K |
| Jan 30, 25 | Peter KolchinskyDirector,TenPercentOwner | BUY | 5.71M | $8.75 | $50.0M |
| Jan 22, 25 | Charles McWherterDirector | BUY | 10.0K | $6.71 | $67K |
| Jan 21, 25 | Charles McWherterDirector | BUY | 5.0K | $6.55 | $33K |
| Jan 15, 25 | Quoc Le-nguyenSee Remarks | SELL | 11.0K | $6.49 | $71K |
| Dec 6, 24 | Rohan PalekarChief Executive Officer | BUY | 5.0K | $7.89 | $39K |
| Dec 5, 24 | Charles McWherterDirector | BUY | 10.0K | $8.00 | $80K |
| Nov 22, 24 | Rohan PalekarChief Executive Officer | BUY | 10.0K | $8.35 | $84K |
| Oct 30, 24 | Quoc Le-nguyenSee Remarks | SELL | 28.0K | $8.12 | $227K |
| Apr 1, 24 | Rohan PalekarChief Executive Officer | SELL | 52.7K | $10.91 | $575K |
| Mar 4, 24 | Peter KolchinskyDirector,TenPercentOwner | BUY | 1.35M | $15.35 | $20.7M |
| Feb 26, 24 | Rohan PalekarChief Executive Officer | SELL | 4.5K | $10.76 | $48K |
| Dec 29, 23 | Rohan PalekarChief Executive Officer | SELL | 50.0K | $11.20 | $560K |
| Jul 17, 23 | Kathleen LaporteDirector | SELL | 12.5K | $18.80 | $235K |
| Jun 5, 23 | Rohan PalekarChief Executive Officer | SELL | 15.0K | $20.00 | $300K |
| Jun 1, 23 | Edward Morrow Atkinson IIIDirector | SELL | 6.3K | $17.91 | $112K |
| May 9, 23 | Quoc Le-nguyenSee Remarks | SELL | 13.7K | $18.11 | $248K |
| Apr 4, 23 | Ryan MartinsChief Financial Officer | SELL | 8.7K | $14.95 | $130K |
| Mar 28, 23 | Michael R HaydenDirector | BUY | 61.5K | $16.15 | $994K |
| Mar 24, 23 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 2.46M | $16.25 | $40.0M |
| Mar 23, 23 | Ryan MartinsChief Financial Officer | SELL | 5.0K | $16.11 | $81K |
| Mar 23, 23 | Rohan PalekarChief Executive Officer | SELL | 15.0K | $16.00 | $240K |
| Mar 1, 23 | Edward Morrow Atkinson IIIDirector | SELL | 10.0K | $13.60 | $136K |
| Feb 21, 23 | Ryan MartinsChief Financial Officer | SELL | 2.5K | $13.89 | $35K |
| Feb 8, 23 | Ryan MartinsChief Financial Officer | SELL | 1.5K | $14.41 | $21K |
| Feb 3, 23 | Ryan MartinsChief Financial Officer | SELL | 3.0K | $13.11 | $39K |
| Jan 3, 23 | Ryan MartinsChief Financial Officer | SELL | 5.9K | $12.51 | $74K |
| Oct 18, 22 | Ra Capital Nexus Fund, L.p.Director,TenPercentOwner | BUY | 1.17M | $7.65 | $9.0M |
| Jul 1, 22 | Ra Capital Nexus Fund, L.p.Director,TenPercentOwner | BUY | 2.82M | $3.55 | $10.0M |
| Apr 25, 22 | Michael R HaydenDirector | BUY | 10.0K | $2.67 | $27K |
| Apr 7, 22 | Michael R HaydenDirector | BUY | 10.0K | $3.48 | $35K |
| Mar 30, 22 | Michael R HaydenDirector | BUY | 6.3K | $3.62 | $23K |
| Feb 1, 22 | Ram WaisbourdSee Remarks | SELL | 7.0K | $5.70 | $40K |
| Jan 28, 22 | Rohan PalekarChief Executive Officer | BUY | 2.5K | $6.14 | $15K |
| Jan 27, 22 | Rohan PalekarChief Executive Officer | BUY | 5.0K | $7.50 | $38K |
| Jan 26, 22 | Orbimed Advisors Israel II LtdTenPercentOwner | SELL | 10.7K | $8.38 | $90K |
| Jan 25, 22 | Orbimed Advisors Israel II LtdTenPercentOwner | SELL | 24.5K | $8.40 | $206K |
| Dec 16, 21 | Ram WaisbourdSee Remarks | SELL | 7.0K | $11.48 | $80K |
| Nov 16, 21 | Ram WaisbourdSee Remarks | SELL | 7.0K | $16.49 | $115K |
| Oct 18, 21 | Ram WaisbourdSee Remarks | SELL | 7.0K | $17.49 | $122K |
| Sep 16, 21 | Ram WaisbourdSee Remarks | SELL | 7.0K | $19.46 | $136K |
| Aug 16, 21 | Ram WaisbourdSee Remarks | SELL | 7.0K | $18.28 | $128K |
Over the past 12 months, insiders at 89bio, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on ETNB, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market ETNB insider purchase in our data was $50.0M by Peter Kolchinsky, Director,TenPercentOwner, filed on Jan 30, 25.
0 different insiders at 89bio, Inc. filed open-market SEC Form 4 transactions on ETNB over the last 12 months.
InsiderTape plots every ETNB insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every 89bio, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →